JS

Jainti Singh

Active Director Director DIN 07322832
DIN 07322832 First appointment Dec 2015 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2015
Shareholding value •••• Premium profile

About Jainti Singh

Data last updated:

Jainti Singh is a Director at Jainti Pharmaceuticals Private Limited (since 2015). The company operates in Chemicals. Jainti Pharmaceuticals Private Limited reported revenue of ₹1.9 Lakh (FY 2025).

DIN 07322832
Primary Designation Director
Industry Chemicals
First Appointment 07 Dec 2015
Oldest Company Age 10 yrs
Largest company Jainti Pharmaceuticals Private Limited · ₹1.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Dec 20152015₹1.9 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Jainti Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jainti Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jainti Singh

Jainti Singh currently holds 1 directorship: Jainti Pharmaceuticals Private Limited (Director, since 07 Dec 2015, revenue ₹1.9 Lakh (FY 2025)).

Jainti Singh was first appointed on 07 Dec 2015 as Director at Jainti Pharmaceuticals Private Limited.

The current boards of Jainti Singh's companies include Aparajita Singh (Jainti Pharmaceuticals Private Limited), Malvika Singh (Jainti Pharmaceuticals Private Limited), Shyam Narain Singh (Jainti Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available